Medical University of South Carolina
171 Ashley Avenue
60 articles with Medical University of South Carolina
Kriya Therapeutics secured $270 million that will be used to advance its fully integrated gene therapy pipeline and expand engineering, manufacturing and computation.
Kriya Licenses Next Generation Complement-Targeted Gene Therapies for the Treatment of Geographic Atrophy and Other Ocular Diseases
Kriya Therapeutics, Inc. today announced an exclusive agreement with the Medical University of South Carolina (MUSC) Foundation for Research Development to license next generation complement-targeted gene therapies for the treatment of geographic atrophy and other ocular diseases.
12/28/2021BridgeBio Pharma reported topline data from Part A (Month 12) of its Phase III study of acoramidis for symptomatic transthyretin amyloid cardiomyopathy. The drug failed the study arm.
Energy solutions company begins second phase of the comprehensive energy savings project
American Society of Cannabis Medicine Leaders to Present at the Medical University of South Carolina
The American Society of Cannabis Medicine announced that members of its leadership have been asked to participate at the Second Annual Update on Medical Cannabis Friday, Sept. 27 presented by the Department of Psychiatry and Behavioral Sciences of the Medical University of South Carolina.
As the American College of Cardiology (ACC) annual meeting opens in New Orleans this weekend, one of the big stories will undoubtedly be on the role of wrist sensors, such as the Apple Watch, in identifying heart rhythm problems. There will be other big stories, of course. Here’s a preview of jus...
Medtronic plc (NYSE:MDT) and the Medical University of South Carolina (MUSC) today announced a five-year value-based health care partnership intended to transform and improve care for patients in South Carolina.
MUSC Foundation for Research Development and Cumberland Emerging Technologies Announce Collaboration Agreement
The technology transfer organization for the Medical University of South Carolina, the MUSC Foundation for Research Development, and Cumberland Emerging Technologies Inc. have entered into a collaboration agreement to develop new biomedical products.
MUSC and Siemens Healthineers Form Strategic Partnership to Disrupt and Reshape Health Care Delivery
Institutions aim to enhance value-based care through application of research and engineering expertise
Johnson & Johnson Medical Devices Companies Bring Real-World Evidence To Infection Risk Management To Help Medical University of South Carolina Reduce Infection Risk In The OR
RedHill Biopharma Announces Initiation Of Phase II Study With YELIVA In Hepatocellular Carcinoma At Medical University of South Carolina
S.C. Mosquitoes Likely To Carry Zika, But Health Experts Don’t Expect Major Disease Outbreak, Medical University of South Carolina Study
New Device For Heart Failure Patients Fail To Improve Primary Outcomes, Medical University of South Carolina Study
Ymir Genomics And Medical University of South Carolina Announce Collaboration To Discover Urine Bladder Cancer Biomarkers
Medical University of South Carolina And Bristol-Myers Squibb Announce Translational Research Collaboration Focused On Fibrotic Diseases
AEterna Zentaris Signs Transfer Agreement Of Its Discovery Library With The Medical University of South Carolina